Comgest Global Investors S.A.S. Buys 2,159 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Comgest Global Investors S.A.S. raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 11.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 20,306 shares of the medical equipment provider's stock after acquiring an additional 2,159 shares during the quarter. Comgest Global Investors S.A.S.'s holdings in Intuitive Surgical were worth $9,976,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Ridgewood Investments LLC bought a new stake in shares of Intuitive Surgical in the second quarter worth $26,000. Godsey & Gibb Inc. grew its stake in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after buying an additional 35 shares during the period. Creekmur Asset Management LLC lifted its stake in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider's stock valued at $25,000 after buying an additional 42 shares in the last quarter. LGT Financial Advisors LLC raised its stake in shares of Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock worth $30,000 after purchasing an additional 54 shares during the last quarter. Finally, LRI Investments LLC purchased a new stake in shares of Intuitive Surgical in the first quarter worth approximately $30,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on ISRG shares. JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $495.00 to $575.00 and gave the company an "overweight" rating in a research report on Friday, October 11th. Piper Sandler reiterated an "overweight" rating and set a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Oppenheimer restated a "market perform" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Redburn Atlantic upgraded shares of Intuitive Surgical from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $380.00 to $510.00 in a report on Friday, August 2nd. Finally, Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an "overweight" rating in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $513.74.

Intuitive Surgical Price Performance

Shares of ISRG traded down $10.19 during midday trading on Friday, hitting $527.61. 1,447,901 shares of the company traded hands, compared to its average volume of 1,461,285. The stock has a 50-day moving average of $499.29 and a 200-day moving average of $457.28. Intuitive Surgical, Inc. has a one year low of $295.02 and a one year high of $544.38. The firm has a market cap of $187.92 billion, a P/E ratio of 84.82, a PEG ratio of 5.28 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the company's stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the transaction, the senior vice president now owns 3,001 shares in the company, valued at approximately $1,461,006.84. This represents a 93.06 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Amy L. Ladd sold 450 shares of the firm's stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the transaction, the director now owns 821 shares of the company's stock, valued at approximately $402,519.88. The trade was a 35.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 91,178 shares of company stock valued at $45,897,071 over the last 90 days. Insiders own 0.90% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.